Last week, we spent time with some of the best and brightest minds in oncology at ASCO 2016 in Chicago. Speaking with so many professionals who are passionately advancing new therapies is a privilege and motivates our team to work even harder with our sponsors to develop the new treatments that are significantly improving the outcomes for patients.
The annual meeting was attended by more than 30,000 oncology professionals from around the world and covered state-of-the-art treatment modalities, new therapies and ongoing controversies in the field.
Not only did we exhibit at the conference where we met many of our drug development colleagues, we also hosted an open house and networking event with pharma and biotech companies and investigators from around the globe at our beautiful suite overlooking Lake Michigan and McCormick Place.
Meet Our Oncology Team:
Barb Geiger, BSN, RN
Executive Vice President, Clinical Operations
Barb has more than 25 years of experience in the conduct and management of Phase I-IV clinical trials and in the evaluation and selection of global clinical trial vendors. Prior to founding Worldwide Clinical Research (WWCR) in 2000, she spent 10 years at global CROs. Additionally, Barb spent eight years at a major pharmaceutical company and started her clinical research career in a Phase I/II private research unit.
Peter Langecker, MD, PhD
Executive Medical Director, Global Oncology
Peter has more than 25 years of extensive hands-on experience in establishing and conducting industry-sponsored oncology and hematology clinical research and development according to GCP, GLP and GMP regulations. His primary responsibilities at Clinipace Worldwide include the provision of internal and external drug development, regulatory strategy and medical affairs consulting to Clinipace project teams and clients. Peter’s medical training and published research is focused on preclinical and clinical oncology and the hormonal regulation of breast cancer. He is an author and co-author of more than 50 publications and posters.
Ofelia Rodriguez Nievas, MD
Senior Director of Operations, Latin America
Ofelia is a board-certified medical oncologist based in Buenos Aires, Argentina. After spending 20 years as a practitioner and clinical investigator, she started working in the CRO industry. Over the past 15 years, Ofelia has performed medical affairs activities as a medical monitor and safety physician as well as operational tasks for clinical trials in the region. In her role at Clinipace, which she has held for the past 10 years, she is responsible for overseeing the management of the Latin America office. She is also responsible for business development, operational and medical monitoring activities.
Senior Director, Project Management
Darcy has more than 18 years of pharmaceutical experience in global project management and clinical operations working on both the pharmaceutical and CRO sides. Her therapeutic experience is in oncology (solid tumor and hematology), neuroscience (multiple sclerosis, ADHD, smoking cessation, Alzheimer’s disease, Parkinson’s disease, pain, schizophrenia and depression), women’s health (contraception, pre-term birth and hormone replacement therapy), infectious disease (bacteremia) and clinical pharmacology studies in multiple therapeutic areas. She has project management experience in the United States, Canada, Europe, Russia, Latin America, South Africa, Asia Pacific and Australia. Darcy is also experienced in managing all aspects of Phase I-IV clinical trials, including study design input, organizing DSMB, oversight of final study report (CSR) deliverable, IND and NDA submissions. Darcy has vendor management experience with Phase I units, central laboratories, PK/PD analytical labs, drug warehouses, recruitment vendors, meeting planners and EDC/IVR providers.
Pablo is a biochemist with extensive oncology experience. He has been in the clinical research industry for more than 15 years. As a clinical operations professional, he has managed Phase I to Phase IV local (Argentina), regional (Latin America) and global clinical trials.